The in-vivo effects of alloxan on protein oxidation and lipid peroxidation, as well as on proteasome and antioxidant enzyme activities in liver and kidney of copper-loaded and iron-loaded rats, were studied. In control animals, a single alloxan dose (120 mg/kg, i.p.) increased blood-glucose concentration at the 24 th hr and 48 th hr and, especially, on the 5 th day. For these periods of alloxan action, no changes in lipid peroxidation and antioxidant enzyme activities were found; only a slight increase of carbonyl content and strong increase of trypsin-like proteasome activity in rat liver on the 5 th day was observed. Five days after alloxan injection, the blood-glucose concentration in iron-pretreated rats was similar to that of the controls. However, it was significantly lower in copper-pretreated animals; hence, insulin-mimetic action of copper might be suggested. The lower proteasome activity, measured in liver of copper-pretreated diabetic rats is probably due to a potential copper-chelating ability of alloxan.
Introduction
Alloxan is a substance often used in laboratory practice for inducing of experimental diabetes. It is assumed that the cytotoxic action of alloxan is mediated by reactive oxygen species (ROS). Their formation is preceded by alloxan reduction to dialuric acid; it occurs in the presence of different reducing agents, like ascorbate [1] , GSH, cysteine and protein-bound SH groups, including SH-containing enzymes [2, 3] . The re-oxidation of dialuric acid back to alloxan leads to superoxide radicals (O − 2 ) and hydrogen peroxide (H 2 O 2 ) generation; in the reaction between alloxan and dialuric acid, intermediate alloxan radicals (AH . ) are also formed [4, 5] . During dialuric acid auto-oxidation, the presence of transition metal ions results in production of hydroxyl radicals, . OH [6] , which are believed to be the main toxic agent in diabetes [7] [8] [9] . It is well known that . OH are highly reactive and damaging for cells and that their formation is possible only in the presence of transition metals, as iron and copper, and H 2 O 2 , i.e. realizing a Fenton-type reaction [10, 11] . The participation of . OH in diabetic toxicity and the need of transition metals for . OH formation in redox-cycling systems, like alloxan/dialuric acid, justify studies on the in-vivo effects of different metals in alloxaninduced diabetes.
There are data that inorganic compounds (lithium, selenium, vanadium, molybdenum) are able to mimic insulin effects, both in vivo and in vitro [12] [13] [14] [15] [16] . Moreover, it has been found in vitro that vanadium, unlike iron, has no additive effects on AH 2 -induced changes in lipid peroxidation and antioxidant enzyme activities [17] . All these findings give ground for further experimental research, with respect to evaluation of the role of different metals in alloxan-induced experimental diabetes.
Therefore, a study of in-vivo alloxan effects on lipid peroxidation and antioxidant defense systems (natural enzyme and non-enzyme antioxidants) in copper-and ironpretreated animals is of interest. From a toxicological standpoint, the ubiquitin-proteasome system is also considered to be a cellular defense-mechanism, since it is involved in the removal of damaged proteins, generated by adduct formation and oxidative stress [18, 19] . It is believed that the selective removal of the oxidized proteins by the 20S proteasome is an essential part of antioxidant defense against oxidative stress [20, 21] .
The aim of this comparative study was to investigate the in-vivo effects of alloxan on protein oxidation and lipid peroxidation, as well as on proteasome and antioxidant enzyme activities in liver and kidney of copper-loaded and iron-loaded rats.
Materials and methods

Substances
Alloxan was purchased from BDH, dialuric acid from Riedel-de Haen AG, NBT from Serva, H 2 O 2 and riboflavin from Merck. All other reagents used were analytical grade. The solutions used in the present experiments were prepared with de-ionized water.
Animals and treatment
Male Wistar rats, weighing 160-180g, were housed at 22 o -25 o C, with an alternating 12-h light-dark cycle. The rats (controls and metal-loaded) were given free access to tap water and a standard laboratory diet. Three models of metal-loading with drinking water were used. The animals received 0.27 mg CuSO 4 .5H2O/ml (I experimental model), 0.67 mg or 2.67 mg CuSO 4 .5H2O/ml (II experimental model) and 0.67 mg CuSO 4 .5H2O/ml or 0.67 mg FeCl 3 .6H 2 O/ml (III experimental model). In all experimental models, the animals were divided into two groups (control and metal-loaded rats), each of 12 animals. After two weeks, half of the animals in each group were treated with a single alloxan dose (120 mg/kg, i.p.). Instead of water, the alloxan-untreated rats received glucose solution (5 % in drinking water), while the metal-loaded rats were given the same glucose solution + corresponding metal salt. The animals were fasted for 24 hrs prior to the experiments and were killed by decapitation under light ether anesthesia 24 hrs (I experimental model), 48 hrs (II experimental model) or 5 days (III experimental model) after alloxan injection.
Tissue preparations
Blood was taken by a heparinized syringe, through puncture of the heart left ventricle of the rats, under light ether anaesthesia and centrifuged for 10 min at 3000 rpm for obtaining blood serum. Liver, perfused with cooled 0.15M KCl, was used for obtaining a 10 % homogenate in 0.15M KCl. It was centrifuged for 10 min at 600 g in order to obtain a "post-nuclear" homogenate. Part of it was centrifuged at 100 000 g for obtaining a cytosolic fraction.
A 10 % kidney homogenate in 0.15M KCl was also obtained. It was centrifuged for 10 min at 600g for obtaining a "post-nuclear" homogenate.
Analytical methods
Protein content was measured by the method of Lowry et al. (1951) [22] .
Blood glucose concentration was measured by Glucose-PAP enzymatic-colorimetric method (ABX Diagnostics, France) and was expressed in mg %.
Protein carbonyl content was quantified by reaction with 2,4-dinitrophenylhydrazine (2,4-DNPH), according to Whitekus et al. (2002) [23] , with some modifications. 0.5 ml samples (1 mg protein/ml) were incubated with 1.5 ml 10mM 2.4-DNPH (in 2M HCl) at room temperature for 1 h. After addition of 1 ml 40 % TCA, the samples were centrifuged for 3 min at 11 000 g. The pellets were washed 3-times with ethanol-ethyl (1:1 v/v) and dissolved in 6M guanidine in 20 mM potassium phosphate buffer, pH 2.3 (adjusted with HCl). The absorbance at 366 nm was measured and the carbonyl content was expressed in nmoles carbonyls per mg protein, using a molar extinction coefficient of
Peptidase activity of proteasomes was measured according to Bulteau et al. (2001) [24] . The liver cytosolic fraction was assayed for trypsin-like activity, using the fluorogenic peptide N-t-Boc-Leu-Ser-Thr-Arg-7-amido-4-methyl-coumarin (LSTR-MCA). The values, measured at 365 nm (excitation) and 465 nm (emission) were expressed in fluorescent units (FU) per mg protein.
Lipid peroxidation (LP) was determined by the amount of thio-barbituric acid reactive substances (TBARs), formed in fresh liver and kidney homogenates after a 60-min incubation at 37
• [25] . The A 600 was considered to be a nonspecific base line and was subtracted from A 532 . The values were expressed in nmoles malondialdehyde per mg protein, using a molar extinction coefficient of 1.56
Total glutathione level in tissue post-nuclear homogenates was measured according to Tietze (1969) [26] . The values were measured at 412 nm and expressed in ng per mg protein, using GSSG as a reference standard.
Glutathione peroxidase (GSH-PER) activity (with t-butylhydroperoxide as a substrate) was measured by the method of Gunzler et al. (1972) [27] . The values, measured at 340 nm, were expressed in nmoles NADPH oxidized per min per mg protein, using a molar extinction coefficient of 6.22
Glutathione reductase (GSSG-RED) activity was measured by the method of Pinto and Bartley (1969) [28] . The values, measured at 340 nm, were expressed in nmoles NADPH oxidized per min per mg protein, using a molar extinction coefficient of 6.
Glucose-6-phosphate dehydrogenase (Glu-6-P-DH) activity was determined after Cartier et al. (1967) [29] . The values, measured at 340 nm, were expressed in nmoles NADP + reduced per min per mg protein, using a molar extinction coefficient of 6.
Superoxide dismutase (SOD) activity was determined according to Beauchamp and Fridovich (1971) [30] . The samples were lighted for 5 min with 250W HgL lamp and O − 2 -provoked nitroblue tetrazolium (NBT)-reduction was measured at 560 nm. The results were expressed as U per mg protein (one unit of SOD activity is the amount of the enzyme, inhibiting the NBT reduction by 50 %).
Statistic Analysis
The results were statistically analyzed by one-way ANOVA (Dunnett post-test), p<0.01 being accepted as the minimum level of statistical significance of the established differences.
The experiments have been performed according to the "Principles of laboratory animal care" (NIH publication No. 85-23, revised 1985) , and the rules of the Ethics Committee of the Institute of Physiology, Bulgarian Academy of Sciences (registration FWA 00003059 by the US Department of Health and Human Services).
Results
For two weeks, the controls, the copper-and iron-pretreated rats gained weight at an equal rate, except the animals receiving 2.67 mg CuSO 4 .5H2O/ml (a dose, equivalent to 10.24mg Cu/rat/day). The smaller body weight changes of these copper-loaded animals were in good correlation with the decreased consumption of water and food (Table 1) .
On the 5 th day after alloxan injection (III experimental model), the animals from control (metal-untreated) and iron-treated groups put on weight at an equal rate (11±3.8 and 7±3.9 g for week, respectively). However, the copper-pretreated animals lost weight (10±4.9 g in a week), irrespective of the equal copper and iron doses; in comparison to controls and iron-pretreated animals, the quantity of drank water by the copperpretreated rats was lower ( Table 1) . The administration of a single alloxan dose in control animals increased blood-glucose concentration, the highest glucose level being measured on the 5 th day after alloxan injection (Table 1) . Similar blood-glucose changes were observed in the iron-pretreated rats; however, in copper-loaded animals, a lower blood glucose concentration was measured, depending on the copper dose and time of alloxan action. Thus, the blood-glucose concentration in animals, receiving more than 4-5 mg Cu/day, reached the values of control (alloxan-untreated) rats. The alloxan effects on spontaneous lipid peroxidation (measured as TBARs formation) and protein oxidation (measured as carbonyl content) in liver of control and metalpretreated animals were also studied. No changes in spontaneous TBARs levels in liver (Table 2 ) and kidney (values between 0.7±0.15 and 1.1±0.19 were measured) of metaluntreated and metal-pretreated animals were found. On the 5 th day after alloxan injection, a slight increase in liver carbonyl content of metal-untreated animals was observed; however, neither copper-nor iron-pretreatment significantly changed it (Table 3) . The importance of proteasomes in removing oxidized cell proteins was the reason to study alloxan effects on proteasome activity. As shown on Table 3 , the liver trypsinlike proteasome activity was the same in alloxan-untreated controls, iron-and copperpretreated animals. On the 5 th day after alloxan injection, this activity was strongly increased in liver of controls and iron-pretreated animals (about 2-fold), but a weaker activity was measured in liver of copper-pretreated rats.
Having in mind the metal overload of rat tissues (a result of metal pretreatment) and the redox-cycling nature of alloxan, changes in enzyme and non-enzyme antioxidant defense systems might be also expected. In iron-pretreated rats, the level of liver GSH (the main non-enzyme antioxidant) was similar to that in controls, but it increased dosedependently in copper-loaded ones. This copper-induced increase in GSH-level disappeared at the 48 th hr and strongly decreased on the 5 th day after alloxan injection (Table   4) . A decrease in liver GSH level of iron-pretreated diabetic rats was also observed on the 5 th day after alloxan administration. 
Table 4 Effects of alloxan on GSH-level in rat liver homogenates of metal-pretreated rats
Two weeks after copper-, but not after iron-, pretreatment of the animals, changes in antioxidant enzyme activities were also observed: 4.10 mg Cu/day led to increase of liver Glu-6-P-DH activity and the highest Cu-dose (10.24 mg/rat/day), used in the present experiments, enhanced both GSH-PER and Glu-6-P-DH activities in liver (Table 5a and  Table 5b ). In kidney the following values were obtained: with respect to GSH-PER activity, 176±11 for Cu-treated and 118±8 for controls; with respect to Glu-6-P-DH activity, 20±0.4 for Cu-treated and 15±1.2 for controls. However, these Cu-induced changes were preserved after alloxan administration. 
Table 5a
Effects of alloxan on GSH-PER and GSSG-RED activities in rat liver homogenates of metal-pretreated rats. 
Table 5b
Effects of alloxan on Glu-6-P-DH and SOD activities in rat liver homogenates of metal-pretreated rats.
Discussion
Alloxan diabetes is often used as an animal model of insulin-dependent diabetes mellitus. Alloxan mechanism of action in pancreatic β-cells, is described in details by Szkudelski (2001) [31] includes ROS formation with a simultaneous increase in cytosolic calcium concentration, causing a rapid destruction of β-cells. The rapid uptake of alloxan takes place not only in β-cells, but also in liver and other tissues [32, 33] . Oxidative stress and resultant tissue damage is assumed to be hallmarks of chronic disease, diabetes being no exception. The question is whether oxidative stress occurs at an early stage of diabetes, preceding the appearance of complications, or it is merely a consequence of the tissue damage, reflecting the complications. Since the answer of this question is important for medicine, the numerous studies in this field are fully justified. Many investigators consider the important role of O − 2 , NO . and ONOO − in diabetic cardiovascular complications [34, 35] , as well as the sources of oxidative stress in diabetes: non-enzymatic, originating from the oxidative biochemistry of glucose [34] and from the mitochondrial respiratory chain [36] , as well as enzymatic, including NOS, NAD(P)H oxidase and xanthine oxidase [37] [38] [39] . There are many studies on the changes in natural antioxidant status in development diabetes, concerning enzyme [40] [41] [42] and non-enzyme antioxidants [43] [44] [45] . It is well known that alloxan damage depends on animal species, route and dose of administration, nutritional status and duration of its action. Changes in antioxidant status, induced by metal-pretreatment of animals, would also be of significance for alloxan action. Thus, the present experiments were carried out 24 hrs, 48 hrs and 5 days after alloxan injection in controls, copper-and iron-pretreated animals. In spite of the similar Fe-and Cu-consumption for a period of two weeks, changes in the levels of natural enzyme and non-enzyme antioxidants were established only in tissues of copper-loaded group. In controls (metal-untreated animals), administration of alloxan led to time-dependent increase of blood glucose concentration, but no changes in antioxidant defense parameters (TBARs formation, GSH-level, antioxidant enzyme activities) were found at 24 th and 48 th hour. Only, a slight increase of liver carbonyl content and strong increase of tripsin-like proteasome activity on the 5 th day after alloxan injection were measured. Five days after alloxan treatment, an increase of ATP-ubiquitin-dependent proteasome activity has also been reported for skeletal muscle [46] . This alloxan-induced increase in proteasome activity might be the reason for the relatively slight increase of carbonyl level, i.e. a defense role of proteasomes could not be excluded. Concerning the origin of diabetic complications, different hypotheses, including oxidative stress [47] [48] [49] and carbonyl stress [50, 51] are reported. According to Baynes and Thorpe (1999) [52] , the altered metabolism and compromised detoxication results in increased carbonyl formation, increased chemical modification of proteins and then to oxidative stress and tissue damage, which ultimately leads to the development of complications. The present results, obtained in the first days of the alloxan action are in accordance with these considerations; for this short period of alloxan action (24 hrs, 48 hrs and 5 days), the antioxidant defense parameters in tissues of metal-untreated and metal-pretreated animals were unchanged, except the decreased GSH-level in liver of metal-pretreated rats.
In general, in-vivo effects of alloxan on the parameters studied in the present study were similar in metal-untreated and iron-pretreated animals, but not in copper-pretreated ones. The copper-pretreatment provoked both beneficial (decrease of blood glucose concentration) and undesirable effects (reduction of body weight). The decreased blood glucose concentration might be due to an insulin-mimic ability of copper; similar ability is reported for lithium, selenium, vanadium and molybdenum. In-vivo formed copper complexes of alloxan and/or dialuric acid would explain the decrease of alloxan-induced proteasome activity in liver of copper-loaded animals; it has been found that organic copper complexes are able to inhibit, potently and selectively, the proteasome activity [53] . The present in-vivo study showed that copper-, but not iron-loading led to changes in the indices evaluated in blood, liver and kidney of control and diabetic rats. Rats have a high tolerance to copper excess: 100-300 ppm (0.1-0.3 mg/ml) cupric sulfate, administered to rats in drinking water, produce no damaging effects, whilst more that 3000-30000 ppm (3-30 mg/ml) is lethal to rats within two weeks [54] . The increase of tissue copper levels resulted in extensive liver necrosis and associated inflammatory responses [55] . Although the animals (in present work) were chronically treated with comparatively low copper doses (0.27-2.67 mg/ml), some changes in antioxidant parameters were found after two weeks. The use of in-vivo models with longer time of copper and/or alloxan action is also of interest. Moreover, similar studies with other metal-pretreatments would contribute to clearer estimation of the role of different metals in diabetes development, especially in regions with environmental metal contamination.
